DLRHX Mutual Fund

NAV$26.45

Fund Essentials - as of Mar 31, 2026

Net Assets
$2M
Expense Ratio
1.46%
Dividend Yield (Current)
10.73%
Holdings
106
Inception Date
Jan 28, 2010
Fund Family
Nomura Asset Management Co Ltd
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually
SEC 30-Day Yield
••••••••••

Performance

YTD+5.00%
1 Year+31.32%
3 Year+18.51%
5 Year+12.82%
10 Year+14.07%

Asset Allocation

Stocks: 96.77%
Cash: 2.42%
Other: 0.81%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
UCB:BRUcb Sa5.90%
REGNRegeneron Pharmaceuticals, Inc.5.46%
PFEPfizer, Inc.4.84%
GILDGilead Sciences Inc4.40%
ABBVAbbvie Inc4.09%
Top 10 Concentration: 43.07%Report Date: Mar 31, 2026
Download all 106 holdings for DLRHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.73%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

DLRHX Mutual Fund Overview

DLRHX Mutual Fund (Nomura Healthcare Fund Class R) is managed by Nomura Asset Management Co Ltd with $2.3M in net assets. DLRHX expense ratio is 1.46%, holding 106 positions across sectors including Health Care, Unknown, Financials. Inception date: 2010-01-28.

DLRHX performance shows a YTD return of 5.00%. The 1-year return is 31.32% and the 5-year return is 12.82%. DLRHX dividend yield stands at 10.73%, paid annually.

DLRHX top holdings include Ucb Sa (5.9%), Regeneron Pharmaceuticals, Inc. (5.5%), Pfizer, Inc. (4.8%), Gilead Sciences Inc (4.4%), Abbvie Inc (4.1%). View all DLRHX holdings, sector breakdown, or dividend history.

DLRHX can be compared against other funds using the overlap calculator or side-by-side comparison tool. DLRHX alternatives are available via the screener, along with tax-loss harvesting opportunities.